MK-8189 Safety and Tolerability in Participants With Alzheimer’s Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis
The purpose of this study is to evaluate the safety and tolerability of multiple ascending doses of MK-8189 in participants with Alzheimer’s Disease (AD) with or without symptoms of agitation-aggression and/or